Combined assessment of thrombolysis in myocardial infarction flow grade, myocardial perfusion grade, and ST-segment resolution to evaluate epicardial and myocardial reperfusion

American Journal of Cardiology

Volumn 93, Issue 11, 2004, Pages 1362-1367

  Giugliano, Robert P ^a   Sabatine, Marc S ^b   Gibson, C Michael ^b   Roe, Matthew T ^b   Harrington, Robert A ^b   Murphy, Sabina A ^b   Morrow, David A ^b   Antman, Elliott M ^b   Braunwald, Eugene ^b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; ENOXAPARIN; EPTIFIBATIDE; FIBRINOGEN RECEPTOR ANTAGONIST; FIBRINOLYTIC AGENT; HEPARIN; TENECTEPLASE; TIROFIBAN;

ANGIOCARDIOGRAPHY; ARTICLE; BLOOD CLOT LYSIS; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; ELECTROCARDIOGRAM; EPICARDIUM; FIBRINOLYTIC THERAPY; HEART DEATH; HEART INFARCTION; HEART MUSCLE BLOOD FLOW; HEART MUSCLE PERFUSION; HEART MUSCLE REPERFUSION; HUMAN; MAJOR CLINICAL STUDY; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; PREDICTION; PRIORITY JOURNAL; ST SEGMENT; ST SEGMENT ELEVATION; TREATMENT OUTCOME;

ANTIBODIES, MONOCLONAL; CLINICAL TRIALS, PHASE II; COHORT STUDIES; CORONARY ANGIOGRAPHY; ELECTROCARDIOGRAPHY; ENOXAPARIN; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; IMMUNOGLOBULIN FAB FRAGMENTS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; THROMBOLYTIC THERAPY; TIME FACTORS; TISSUE PLASMINOGEN ACTIVATOR; TYROSINE;

EID: 2542456610     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2004.02.031     Document Type: Article

References (30)

1. Dalen J.E., Gore J.M., Braunwald E., Borer J., Goldberg R.J., Passamani E.R., Forman S., Knatterud G. Six- and twelve-month follow-up of the phase I Thrombolysis In Myocardial Infarction (TIMI) Trial. Am J Cardiol. 62:1988;179-185
2. Gibson C.M., Cannon C.P., Murphy S.A., Ryan K.A., Mesley R., Marble S.J., McCabe C.H., van de Werf F., Braunwald E. Relationship of TIMI myocardial perfusion grade to mortality after administration of thrombolytic drugs. Circulation. 101:2000;125-130
3. Wegscheider K., Neuhaus K.L., Dissmann R., Tebbe U., Zeymer U., Schroder R. Prognostic significance of ST segment change in acute myocardial infarct. Herz. 24:1999;378-388
4. Gibson C.M., Cannon C.P., Murphy S.A., Marble S.J., Barron H.V., Braunwald E. Relationship of the TIMI myocardial perfusion grades, flow grades, frame count, and percutaneous coronary intervention to long-term outcomes after thrombolytic administration in acute myocardial infarction. Circulation. 105:2002;1909-1913
5. Gibson C.M., Cannon C.P., Daley W.L., Dodge J.T. Jr, Alexander B. Jr, Marble S.J., McCabe C.H., Raymond L., Fortin T., Poole W.K., et al. TIMI frame count a quantitative method of assessing coronary artery flow. Circulation. 93:1996;879-888
6. Ito H., Tomooka T., Sakai N., Yu H., Higashino Y., Fujii K., Masuyama T., Kitabatake A., Minamino T. Lack of myocardial perfusion immediately after successful thrombolysis. A predictor of poor recovery of left ventricular function in anterior myocardial infarction. Circulation. 85:1992;1699-1705
7. de Lemos J.A., Antman E.M., Giugliano R.P., McCabe C.H., Murphy S.A., van de Werf F., Gibson C.M., Braunwald E. ST-segment resolution and infarct-related artery patency and flow after thrombolytic therapy Thrombolysis In Myocardial Infarction (TIMI) 14 Investigators. Am J Cardiol. 85:2000;299-304
8. Angeja B.G., Gunda M., Murphy S.A., Sobel B.E., Rundle A.C., Syed M., Asfour A., Borzak S., Gourlay S.G., Barron H.V., et al. TIMI myocardial perfusion grade and ST segment resolution association with infarct size as assessed by single photon emission computed tomography imaging. Circulation. 105:2002;282-285
9. Antman E.M., Louwerenburg H.W., Baars H.F., Wesdorp J.C., Hamer B., Bassand J.P., Bigonzi F., Pisapia G., Gibson C.M., Heidbuchel H., et al. Enoxaparin as adjunctive antithrombin therapy for ST-elevation myocardial infarction results of the ENTIRE-Thrombolysis In Myocardial Infarction (TIMI) 23 Trial. Circulation. 105:2002;1642-1649
10. Giugliano R.P., Roe M.T., Harrington R.A., Gibson C.M., Zeymer U., van de Werf F., Baran K.W., Hobbach H.P., Woodlief L.H., Hannan K.L., et al. Combination reperfusion therapy with eptifibatide and reduced-dose tenecteplase for ST-elevation myocardial infarction results of the Integrilin and Tenecteplase in Acute Myocardial Infarction (INTEGRITI) Phase II Angiographic Trial. J Am Coll Cardiol. 41:2003;1251-1260
11. Ohman EM, van de Werf F, Antman EM, Califf RM, de Lemos JA, Gibson CM, Oliverio RL, Harrelson L, McCabe CH, DiBattiste PM, et. al, Investigators for the FASTER-TIMI 24 Trial. Tenecteplase and tirofiban in ST-segment elevation acute myocardial infarction: results of a randomised trial. Am Heart J. In press
12. Chesebro J.H., Knatterud G., Roberts R., Borer J., Cohen L.S., Dalen J., Dodge H.T., Francis C.K., Hillis D., et al. Thrombolysis In Myocardial Infarction (TIMI) Trial, phase I a comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge. Circulation. 76:1987;142-154
13. Schroder R., Dissmann R., Bruggemann T., Wegscheider K., Linderer T., Tebbe U., Neuhaus K.L. Extent of early ST segment elevation resolution a simple but strong predictor of outcome in patients with acute myocardial infarction. J Am Coll Cardiol. 24:1994;384-391
14. Antman E.M., Giugliano R.P., Gibson C.M., McCabe C.H., Coussement P., Kleiman N.S., Vahanian A., Adgey A.A., Menown I., Rupprecht H.J., et al. Abciximab facilitates the rate and extent of thrombolysis results of the Thrombolysis In Myocardial Infarction (TIMI) 14 Trial. The TIMI 14 Investigators. Circulation. 99:1999;2720-2732
15. Gibson CM, Murphy SA, Morrow DA, Aroesty JM, Gibbons RJ, Gourlay SG, Barron HV, Giugliano RP, Antman EM, Braunwald E. Angiographic perfusion score: an angiographic variable that integrates both epicardial and tissue level perfusion before and after facilitated percutaneous coronary intervention in acute myocardial infarction. Am Heart J. In press
16. Stone G.W., Peterson M.A., Lansky A.J., Dangas G., Mehran R., Leon M.B. Impact of normalized myocardial perfusion after successful angioplasty in acute myocardial infarction. J Am Coll Cardiol. 39:2002;591-597
17. Poli A., Fetiveau R., Vandoni P., del Rosso G., D'Urbano M., Seveso G., Cafiero F., De Servi S. Integrated analysis of myocardial blush and ST-segment elevation recovery after successful primary angioplasty real-time grading of microvascular reperfusion and prediction of early and late recovery of left ventricular function. Circulation. 106:2002;313-318
18. Feldman L.J., Coste P., Furber A., Dupouy P., Slama M.S., Monassier J.P., Tron C., Lafont A., Faraggi M., Le Guludec D., et al. Incomplete resolution of ST-segment elevation is a marker of transient microcirculatory dysfunction after stenting for acute myocardial infarction. Circulation. 107:2003;2684-2689
19. Henriques J.P., Zijlstra F., van 't Hof A.W., de Boer M.J., Dambrink J.H., Gosselink M., Hoorntje J.C., Suryapranata H. Angiographic assessment of reperfusion in acute myocardial infarction by myocardial blush grade. Circulation. 107:2003;2115-2119
20. Dibra A., Mehilli J., Dirschinger J., Pache J., Neverve J., Schwaiger M., Schomig A., Kastrati A. Thrombolysis In Myocardial Infarction myocardial perfusion grade in angiography correlates with myocardial salvage in patients with acute myocardial infarction treated with stenting or thrombolysis. J Am Coll Cardiol. 41:2003;925-929
21. de Lemos J.A., Braunwald E. ST segment resolution as a tool for assessing the efficacy of reperfusion therapy. J Am Coll Cardiol. 38:2001;1283-1294
22. Stone G.W., Cox D., Garcia E., Brodie B.R., Morice M.C., Griffin J., Mattos L., Lansky A.J., O'Neill W.W., Grines C.L. Normal flow (TIMI-3) before mechanical reperfusion therapy is an independent determinant of survival in acute myocardial infarction analysis from the Primary Angioplasty in Myocardial Infarction Trials. Circulation. 104:2001;636-641
23. Dauerman H.L., Sobel B.E. Synergistic treatment of ST segment elevation myocardial infarction with pharmacoinvasive recanalization. J Am Coll Cardiol. 42:2003;646-651
24. Montalescot G., Barragan P., Wittenberg O., Ecollan P., Elhadad S., Villain P., Boulenc J.M., Morice M.C., Maillard L., Pansieri M., et al. Platelet glycoprotein IIb/IIIa inhibition with coronary stenting for acute myocardial infarction. N Engl J Med. 344:2001;1895-1903
25. Ross A.M., Coyne K.S., Reiner J.S., Greenhouse S.W., Fink C., Frey A., Moreyra E., Traboulsi M., Racine N., Riba A.L., et al. A randomized trial comparing primary angioplasty with a strategy of short-acting thrombolysis and immediate planned rescue angioplasty in acute myocardial infarction the PACT Trial. PACT Investigators. Plasminogen-Activator Angioplasty Compatibility Trial. J Am Coll Cardiol. 34:1999;1954-1962
26. Scheller B., Hennen B., Hammer B., Walle J., Hofer C., Hilpert V., Winter H., Nickenig G., Bohm M. Beneficial effects of immediate stenting after thrombolysis in acute myocardial infarction. J Am Coll Cardiol. 42:2003;634-641
27. de Lemos J.A., Antman E.M., Giugliano R.P., McCabe C.H., Cutler S.S., Charlesworth A., Schroder R., Braunwald E. InTIME-II Investigators. Comparison of a 60- versus 90-minute determination of ST-segment resolution after thrombolytic therapy for acute myocardial infarction. Am J Cardiol. 86:2000;1235-1237
28. GUSTO V Investigators, Topol E.J. Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition the GUSTO V randomised trial. Lancet. 357:2001;1905-1914
29. Assessment of the Safety and Efficacy of a New Thrombolytic Regimen (ASSENT)-3 Investigators. Efficacy and safety of tenecteplase in combination with enoxaparin, abciximab, or unfractionated heparin the ASSENT-3 randomised trial in acute myocardial infarction. Lancet. 358:2001;605-613
30. Hozumi T., Kanzaki Y., Ueda Y., Yamamuro A., Takagi T., Akasaka T., Homma S., Yoshida K., Yoshikawa J. Coronary flow velocity analysis during short term follow up after coronary reperfusion use of transthoracic Doppler echocardiography to predict regional wall motion recovery in patients with acute myocardial infarction. Heart. 89:2003;1163-1168